Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Abrupt Discontinuation of Saredutant in Depression
NCT00429260Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2007
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of saredutant in major depressive disorder (MDD), sponsored by Sanofi. Started Jan 2007; status: completed.
02
Drugs
saredutant
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00429260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429260.